China Healthy Aging Cohort Study
Launched by XUANWU HOSPITAL, BEIJING · Jun 23, 2024
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
The China Healthy Aging Cohort Study is a research project aimed at understanding the risk factors that may lead to disability and dementia in older adults living in China. Starting in 2024, this study will follow a group of seniors aged 60 and older to gather important information about their health and daily life. Researchers hope to use this information to create a model that can help predict who might be at risk for these conditions in the future.
To participate in this study, individuals must be at least 60 years old, have lived in their community for more than a year, and be able to complete a survey about their health. Participants will be asked to sign a consent form to confirm they understand the study and agree to take part. This study is open to everyone, regardless of gender, and is currently looking for volunteers. By joining, participants can help contribute to valuable research that aims to improve the health and well-being of older adults in their communities.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged 60 years or older
- • Lived in the community for more than 1 year
- • Signed the informed consent form
- Exclusion Criteria:
- • Cannot complete the survey
About Xuanwu Hospital, Beijing
Xuanwu Hospital, located in Beijing, is a leading clinical research institution renowned for its commitment to advancing medical knowledge and improving patient care. Affiliated with Capital Medical University, the hospital specializes in neurology and rehabilitation, providing a robust framework for innovative clinical trials. With a multidisciplinary team of experienced researchers and healthcare professionals, Xuanwu Hospital focuses on conducting high-quality, ethically sound studies that aim to explore new treatment modalities and enhance therapeutic outcomes. Through its dedication to research excellence and patient-centered approaches, Xuanwu Hospital plays a pivotal role in the advancement of healthcare solutions both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, , China
Patients applied
Trial Officials
Yi Tang, MD., PhD
Principal Investigator
Xuanwu Hospital, Beijing
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported